Gernot Eberle
Innsbruck, 6020, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Stereotactic radiofrequency ablation as a valid first-line treatment option for hepatocellular adenomas.
Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Published: June 02, 2022
Technical efficacy and local recurrence after stereotactic radiofrequency ablation of 2653 liver tumors: a 15-year single-center experience with evaluation of prognostic factors.
Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Published: March 01, 2022
Correction to: Stereotactic Radiofrequency Ablation of Breast Cancer Liver Metastases: Short- and Long-Term Results with Predicting Factors for Survival.
Journal: Cardiovascular and interventional radiology
Published: June 22, 2021
Correction to: Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases.
Journal: European radiology
Published: June 18, 2021
Stereotactic radiofrequency ablation of tumors at the hepatic venous confluence.
Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: May 18, 2021
Can accurate evaluation of the treatment success after radiofrequency ablation of liver tumors be achieved by visual inspection alone? Results of a blinded assessment with 38 interventional oncologists.
Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Published: December 11, 2020
Stereotactic Radiofrequency Ablation of Breast Cancer Liver Metastases: Short- and Long-Term Results with Predicting Factors for Survival.
Journal: Cardiovascular and interventional radiology
Published: October 28, 2020
Thermal ablation of CT 'invisible' liver tumors using MRI fusion: a case control study.
Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Published: June 03, 2020
Frequency and risk factors for major complications after stereotactic radiofrequency ablation of liver tumors in 1235 ablation sessions: a 15-year experience.
Journal: European radiology
Published: May 18, 2020
Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation.
Journal: European radiology
Published: November 01, 2019
Last Updated: 09/26/2026